Long-term health check for childhood cancer survivors
Part of Blood & lymphatic, Cancer clinical trials.
This trial tracks the long-term health of people who took part in previous Children's Oncology Group studies. It helps doctors understand the lasting effects of cancer treatment and improve care for survivors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must live in the U.S. at the time you join
- You or your parent/guardian must sign a consent form
- You must have participated in a Children's Oncology Group study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a structured follow-up program to help children who survived blood cancers stay healthy and catch any late side effects early. If your child has finished treatment for a blood cancer and is between 1 and 21, this could help them get ongoing care.
This study looks at how your body processes medications after a stem cell transplant from a donor. It aims to find the best way to test your genes to improve future treatments.
This study follows people who survived certain childhood cancers to learn what long-term health effects may happen after treatment. It also compares survivors with siblings to help researchers understand differences that may be related to cancer or treatment.
This trial asks bereaved parents about the quality of care their child received in the last month of life. It aims to improve how hospitals support families when a child with cancer is dying.
This study checks how people do long-term after stem cell transplant, cellular therapy, or gene therapy. It may help doctors track longer-term health effects and recovery and improve future care.
This study looks at the long-term health effects of hematopoietic (blood-forming) stem cell transplants. It may help doctors better understand and manage late side effects for children and teens after transplant.
Hear when a new Leukemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.